Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1980;49(1-2):51-62.
doi: 10.1007/BF01249189.

Effect of lesions of raphe nuclei on the activity of catecholaminergic and serotonergic neurones in various brain regions of the rat in vivo

Effect of lesions of raphe nuclei on the activity of catecholaminergic and serotonergic neurones in various brain regions of the rat in vivo

H Rommelspacher et al. J Neural Transm. 1980.

Abstract

The dorsal raphe nucleus (DRN), the median raphe nucleus (MRN) and the B9 cell groups were lesioned separately. Then, the concentrations of 5-hydroxytryptamine (5-HT), 5-hydroxyindoleacetic acid (5-HIAA), dopamine (DA), 5-hydroxytryptophan (5-HTP) and dopa were measured in various brain regions. The levels of the two latter compounds presumably reflect the activity of serotonergic and catecholaminergic neurones respectively under the experimental conditions. The findings suggest close functional interrelationships between the two types of neurones. Lesions of cell bodies in the DRN cause decreased activity of catecholaminergic neurones in the striatum, the brainstem, the hippocampus, and the hypothalamus. Lesions of the MRN cause increased activity of catecholaminergic mechanisms in the hypothalamus which may be explained by a functional disinhibition after destruction of the MRN. The other brain regions investigated are not affected. Lesions of the B9 cell group elicit increased activity of catecholaminergic neurones in the brainstem and hippocampus.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Brain Res Bull. 1977 Sep-Oct;2(5):323-39 - PubMed
    1. Pol J Pharmacol Pharm. 1977 Nov-Dec;29(6):573-9 - PubMed
    1. Brain Res. 1971 Dec 10;35(1):167-76 - PubMed
    1. J Comp Neurol. 1978 Jun 1;179(3):641-67 - PubMed
    1. Br J Pharmacol. 1973 Aug;48(4):699-714 - PubMed

LinkOut - more resources